"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Controversy surrounded Him & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Ozempic (semaglutide) is a subcutaneous injection used in people with type 2 diabetes. It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

One of the best things about compounded semaglutide (besides the accessible price) is that it typically comes in vials rather than prefilled injection pens. This gives healthcare providers a lot ...

Alongside diet and exercise changes, participants took a once-weekly semaglutide injection or a placebo for 68 weeks. Participants taking semaglutide lost almost 15 percent of their body weight.